Astragalus IV Undermines Multi-Drug Resistance and Glycolysis of MDA-MB-231/ADR Cell Line by Depressing hsa_circ_0001982-miR-206/miR-613 Axis

References

• Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61–70. doi:10.1038/nature1141223000897
   PubMed Web of Science ®Google Scholar
• Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010;363:1938–1948. doi:10.1056/NEJMra100138921067385
   PubMed Web of Science ®Google Scholar
• Guestini F, McNamara KM, Ishida T, Sasano H. Triple negative breast cancer chemosensitivity and chemoresistance: current advances in biomarkers indentification. Expert Opin Ther Targets. 2016;20:705–720. doi:10.1517/14728222.2016.112546926607563
   PubMed Web of Science ®Google Scholar
• Nedeljkovic M, Damjanovic A. Mechanisms of chemotherapy resistance in triple-negative breast cancer-how we can rise to the challenge. Cells. 2019;8:957. doi:10.3390/cells8090957
   PubMed Web of Science ®Google Scholar
• Meng S, Zhou H, Feng Z, et al. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer. 2017;16:94. doi:10.1186/s12943-017-0663-228535767
   PubMed Web of Science ®Google Scholar
• Li Z, Chen Z, Hu G, Jiang Y. Roles of circular RNA in breast cancer: present and future. Am J Transl Res. 2019;11:3945–3954.31396311
   PubMed Web of Science ®Google Scholar
• Li H, Yao G, Feng B, Lu X, Fan Y. Circ_0056618 and CXCR4 act as competing endogenous in gastric cancer by regulating miR-206. J Cell Biochem. 2018;119:9543–9551. doi:10.1002/jcb.2727130129184
   PubMed Web of Science ®Google Scholar
• Tang YY, Zhao P, Zou TN, et al. Circular RNA hsa_circ_0001982 promotes breast cancer cell carcinogenesis through decreasing miR-143. DNA Cell Biol. 2017;36:901–908. doi:10.1089/dna.2017.386228933584
   PubMed Web of Science ®Google Scholar
• Glazar P, Papavasileiou P, Rajewsky N. circBase: a database for circular RNAs. RNA. 2014;20:1666–1670. doi:10.1261/rna.043687.11325234927
   PubMed Web of Science ®Google Scholar
• Dori M, Bicciato S. Integration of bioinformatic predictions and experimental data to identify circRNA-miRNA associations. Genes. 2019;10(9):642. doi:10.3390/genes10090642
   PubMed Web of Science ®Google Scholar
• Li Y, Zheng F, Xiao X, et al. CircHIPK3 sponges miR-558 to suppress heparanase expression in bladder cancer cells. EMBO Rep. 2017;18:1646–1659. doi:10.15252/embr.20164358128794202
   PubMed Web of Science ®Google Scholar
• Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42:D92–97. doi:10.1093/nar/gkt124824297251
   PubMed Web of Science ®Google Scholar
• Sasaki A, Tsunoda Y, Tsuji M, et al. Decreased miR-206 expression in BRCA1 wild-type triple-negative breast cancer cells after concomitant treatment with gemcitabine and a Poly(ADP-ribose) polymerase-1 inhibitor. Anticancer Res. 2014;34:4893–4897.25202071
   PubMed Web of Science ®Google Scholar
• Xiong H, Yan T, Zhang W, et al. miR-613 inhibits cell migration and invasion by downregulating Daam1 in triple-negative breast cancer. Cell Signal. 2018;44:33–42. doi:10.1016/j.cellsig.2018.01.01329339084
   PubMed Web of Science ®Google Scholar
• Wang B, Guo C, Liu Y, et al. Novel nano-pomegranates based on astragalus polysaccharides for targeting ERalpha-positive breast cancer and multidrug resistance. Drug Deliv. 2020;27:607–621. doi:10.1080/10717544.2020.175452932308054
   PubMed Web of Science ®Google Scholar
• Li W, Hu X, Wang S, et al. Characterization and anti-tumor bioactivity of astragalus polysaccharides by immunomodulation. Int J Biol Macromol. 2020;145:985–997. doi:10.1016/j.ijbiomac.2019.09.18931669273
   PubMed Web of Science ®Google Scholar
• Kang JX, Liu J, Wang J, He C, Li FP. The extract of huanglian, a medicinal herb, induces cell growth arrest and apoptosis by upregulation of interferon-beta and TNF-alpha in human breast cancer cells. Carcinogenesis. 2005;26:1934–1939. doi:10.1093/carcin/bgi15415958519
   PubMed Web of Science ®Google Scholar
• Lau FY, Chui CH, Gambari R, et al. Antiproliferative and apoptosis-inducing activity of Brucea javanica extract on human carcinoma cells. Int J Mol Med. 2005;16:1157–1162.16273300
   PubMed Web of Science ®Google Scholar
• Wang PP, Xu DJ, Huang C, Wang WP, Xu WK. Astragaloside reduces the expression level of P-glycoprotein in multidrug-resistant human hepatic cancer cell lines. Mol Med Rep. 2014;9:2131–2137. doi:10.3892/mmr.2014.207424676670
   PubMed Web of Science ®Google Scholar
• Cheng X, Gu J, Zhang M, et al. Astragaloside IV inhibits migration and invasion in human lung cancer A549 cells via regulating PKC-alpha-ERK1/2-NF-kappaB pathway. Int Immunopharmacol. 2014;23:304–313. doi:10.1016/j.intimp.2014.08.02725218161
   PubMed Web of Science ®Google Scholar
• Jiang K, Lu Q, Li Q, et al. Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling. Int Immunopharmacol. 2017;42:195–202. doi:10.1016/j.intimp.2016.10.00127930970
   PubMed Web of Science ®Google Scholar
• He R, Liu P, Xie X, et al. circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a. J Exp Clin Cancer Res. 2017;36:145. doi:10.1186/s13046-017-0614-129037220
   PubMed Web of Science ®Google Scholar
• Sang Y, Chen B, Song X, et al. circRNA_0025202 regulates tamoxifen sensitivity and tumor progression via regulating the miR-182-5p/FOXO3a axis in breast cancer. Mol Ther. 2019;27:1638–1652. doi:10.1016/j.ymthe.2019.05.01131153828
   PubMed Web of Science ®Google Scholar
• Zou FW, Yang SZ, Li WY, et al. circRNA_001275 upregulates Wnt7a expression by competitively sponging miR3703p to promote cisplatin resistance in esophageal cancer. Int J Oncol. 2020;57:151–160. doi:10.3892/ijo.2020.513732319613
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674. doi:10.1016/j.cell.2011.02.01321376230
   PubMed Web of Science ®Google Scholar
• Liu Z, Sun Y, Hong H, et al. 3-bromopyruvate enhanced daunorubicin-induced cytotoxicity involved in monocarboxylate transporter 1 in breast cancer cells. Am J Cancer Res. 2015;5:2673–2685.26609475
   PubMed Web of Science ®Google Scholar
• Jia L, Huang S, Yin X, et al. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction. Life Sci. 2018;208:123–130. doi:10.1016/j.lfs.2018.07.02730025823
   PubMed Web of Science ®Google Scholar
• Mei J, Xu R, Hao L, Zhang Y. MicroRNA-613: a novel tumor suppressor in human cancers. Biomed Pharmacother. 2020;123:109799. doi:10.1016/j.biopha.2019.10979931877552
   PubMed Web of Science ®Google Scholar
• Zhou Y, Wang M, Tong Y, et al. miR-206 promotes cancer progression by targeting full-length neurokinin-1 receptor in breast cancer. Technol Cancer Res Treat. 2019;18:1533033819875168. doi:10.1177/153303381987516831506061
   PubMed Web of Science ®Google Scholar
• Ling C, Liu S, Wang Y, Zhang FC, Du Y. [Role of miR-206/CDK4 in modulating the growth and chemotlerapy sensitivity of ovarian cancer cells]. Nan Fang Yi Ke Da Xue Xue Bao. 2017;37:393–397. [Chinese].28377359
   PubMedGoogle Scholar
• Liu F, Yin R, Chen X, et al. Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma. Biomed Pharmacother. 2019;114:108605. doi:10.1016/j.biopha.2019.10860530904818
   PubMed Web of Science ®Google Scholar
• Xue M, Li G, Sun P, et al. MicroRNA-613 induces the sensitivity of gastric cancer cells to cisplatin through targeting SOX9 expression. Am J Transl Res. 2019;11:885–894.30899388
   PubMed Web of Science ®Google Scholar
• Wang X, Zhao Y, Qian H, et al. The miR-101/RUNX1 feedback regulatory loop modulates chemo-sensitivity and invasion in human lung cancer. Int J Clin Exp Med. 2015;8:15030–15042.26628987
   PubMed Web of Science ®Google Scholar
• Liu H, Chen K, Wang L, et al. miR-613 inhibits Warburg effect in gastric cancer by targeting PFKFB2. Biochem Biophys Res Commun. 2019;515:37–43. doi:10.1016/j.bbrc.2019.05.00131122697
   PubMed Web of Science ®Google Scholar
• Ge X, Lyu P, Cao Z, et al. Overexpression of miR-206 suppresses glycolysis, proliferation and migration in breast cancer cells via PFKFB3 targeting. Biochem Biophys Res Commun. 2015;463:1115–1121. doi:10.1016/j.bbrc.2015.06.06826093295
   PubMed Web of Science ®Google Scholar